Spatio-temporal Analysis of Urban Growth and Its Effects on Wetlands in Rwanda: The Case of Rwampara Wetland in the City of Kigali

This study aimed at analyzing the spatio-temporal patterns of urban growth and its effects on Rwampara wetland, located in the City of Kigali,  Rwanda. First, the study was based on the application of remote sensing technology, where 4 Landsat images (1987, 1999, 2009 & 2018) were  classified using maximum likelihood classification algorithm. This helped in analyzing the Land Use and Land Cover (LULC) trends in the study area. Secondly, it used the existing LULC data for the years 1990, 2000, 2010 and 2018 in order to investigate the overall changes in LULC in Kigali City. Finally, semi-structured interviews were used to collect data from local people and decision-makers about their past and future management strategies of Rwampara wetland. In this regard, 30 local communities (mainly natives from the study area), 15 local government authorities at sector and district levels as well as 4 senior government authorities in the central administration were interviewed. The findings revealed that over the past 4 decades, urban growth in Kigali City has rapidly increased at the expense of resource degradation in Rwampara wetland. Specifically, there has been an increase of about 77% of the built-up area over the last 31 years (1987-2018) which has led to the decrease of the wetland surface area from 24 ha in 1987 to only 7.7 ha in 2018. The results also revealed that demographic factors (i.e. a high population growth rate and high population  densities) were mainly responsible for urban growth and degradation of wetland resources in the area under investigation. Keywords: urban growth, wetland, wetland resources, wetland degradation, wetland managemen

Formulation of water and sanitation policies and strategies: experiences from Rwanda

This paper describes the process of formulation of Rwanda’s National Water Supply and Sanitation Policies and Strategies, which were approved by the Cabinet in December 2016. The major steps in the process included conceptualisation (preparation of a concept note and work plan); constitution of a dedicated task force to oversee the process; engagement of international consultants; literature review and information collection; preparation of background papers; stakeholders’ consultations; preparation of draft polices and strategies; review and quality assurance by the sector working group and the task force; consensus building; finalisation and approval. The process spanned almost two years and cost approximately US$ 170,000, including the cost of external consultants and stakeholders’ consultations. The case of Rwanda provides valuable lessons for other countries that plan to update their national water and sanitation policies and strategies in view of changes in the context and emerging issues and to ensure alignment with the SDGs

The impact of boiling and in vitro human digestion of Solanum nigrum complex (Black nightshade) on phenolic compounds bioactivity and bioaccessibility

CITATION: Moyo, S. M. et al. 2020. The impact of boiling and in vitro human digestion of Solanum nigrum complex (Black nightshade) on phenolic compounds bioactivity and bioaccessibility. Food Research International, 137. doi:10.1016/j.foodres.2020.109720The original publication is available at https://www.sciencedirect.com/journal/food-research-internationalSolanum nigrum complex (Black nightshade) is a wild leafy vegetable with phenolic antioxidant compounds related to the reduction of oxidative stress. Changes in phenolics and bioactivity due to cooking and gastrointestinal digestion of black nightshade were compared to spinach. Predominant compounds of black nightshade were myricetin, quercetin-3-O-robinoside, 3,4-dicaffeoylquinic acid, 3-caffeoylquinic acid, and rutin, which were improved after boiling but reduced after in vitro digestion. Phenolics were reduced after digestion of black nightshade and spinach; however, bioactivity was still retained, especially in preventing oxidative stress in Caco-2 cells. Hence, indicating their potential to reduce oxidative stress related diseases of the digestive tract.https://www.sciencedirect.com/science/article/pii/S0963996920307456?via%3DihubPublishers versio

Spatio-temporal Analysis of Urban Growth and Its Effects on Wetlands in Rwanda: The Case of Rwampara Wetland in the City of Kigali

This study aimed at analyzing the spatio-temporal patterns of urban growth and its effects on Rwampara wetland, located in the City of Kigali, Rwanda. First, the study was based on the application of remote sensing technology, where 4 Landsat images (1987, 1999, 2009 & 2018) were classified using maximum likelihood classification algorithm. This helped in analyzing the Land Use and Land Cover (LULC) trends in the study area. Secondly, it used the existing LULC data for the years 1990, 2000, 2010 and 2018 in order to investigate the overall changes in LULC in Kigali City. Finally, semi-structured interviews were used to collect data from local people and decision-makers about their past and future management strategies of Rwampara wetland. In this regard, 30 local communities (mainly natives from the study area), 15 local government authorities at sector and district levels as well as 4 senior government authorities in the central administration were interviewed. The findings revealed that over the past 4 decades, urban growth in Kigali City has rapidly increased at the expense of resource degradation in Rwampara wetland. Specifically, there has been an increase of about 77% of the built-up area over the last 31 years (1987-2018) which has led to the decrease of the wetland surface area from 24 ha in 1987 to only 7.7 ha in 2018. The results also revealed that demographic factors (i.e. a high population growth rate and high population densities) were mainly responsible for urban growth and degradation of wetland resources in the area under investigation

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa

BACKGROUND: Clinical laboratory reference intervals have not been established in many African countries, and non-local intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African participants. Using laboratory reference intervals derived from other populations excludes potential trial volunteers in Africa and makes AE assessment challenging. The objective of this study was to establish clinical laboratory reference intervals for 25 hematology, immunology and biochemistry values among healthy African adults typical of those who might join a clinical trial. METHODS AND FINDINGS: Equal proportions of men and women were invited to participate in a cross sectional study at seven clinical centers (Kigali, Rwanda; Masaka and Entebbe, Uganda; two in Nairobi and one in Kilifi, Kenya; and Lusaka, Zambia). All laboratories used hematology, immunology and biochemistry analyzers validated by an independent clinical laboratory. Clinical and Laboratory Standards Institute guidelines were followed to create study consensus intervals. For comparison, AE grading criteria published by the U.S. National Institute of Allergy and Infectious Diseases Division of AIDS (DAIDS) and other U.S. reference intervals were used. 2,990 potential volunteers were screened, and 2,105 (1,083 men and 1,022 women) were included in the analysis. While some significant gender and regional differences were observed, creating consensus African study intervals from the complete data was possible for 18 of the 25 analytes. Compared to reference intervals from the U.S., we found lower hematocrit and hemoglobin levels, particularly among women, lower white blood cell and neutrophil counts, and lower amylase. Both genders had elevated eosinophil counts, immunoglobulin G, total and direct bilirubin, lactate dehydrogenase and creatine phosphokinase, the latter being more pronounced among women. When graded against U.S. -derived DAIDS AE grading criteria, we observed 774 (35.3%) volunteers with grade one or higher results; 314 (14.9%) had elevated total bilirubin, and 201 (9.6%) had low neutrophil counts. These otherwise healthy volunteers would be excluded or would require special exemption to participate in many clinical trials. CONCLUSIONS: To accelerate clinical trials in Africa, and to improve their scientific validity, locally appropriate reference ranges should be used. This study provides ranges that will inform inclusion criteria and evaluation of adverse events for studies in these regions of Africa

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

We conducted a double-blind, randomized, placebo-controlled Phase I study of a recombinant replication-defective adenovirus type 5 (rAd5) vector expressing HIV-1 Gag and Pol from subtype B and Env from subtypes A, B and C, given alone or as boost following a DNA plasmid vaccine expressing the same HIV-1 proteins plus Nef, in 114 healthy HIV-uninfected African adults.Volunteers were randomized to 4 groups receiving the rAd5 vaccine intramuscularly at dosage levels of 1×10(10) or 1×10(11) particle units (PU) either alone or as boost following 3 injections of the DNA vaccine given at 4 mg/dose intramuscularly by needle-free injection using Biojector® 2000. Safety and immunogenicity were evaluated for 12 months. Both vaccines were well-tolerated. Overall, 62% and 86% of vaccine recipients in the rAd5 alone and DNA prime - rAd5 boost groups, respectively, responded to the HIV-1 proteins by an interferon-gamma (IFN-γ) ELISPOT. The frequency of immune responses was independent of rAd5 dosage levels. The highest frequency of responses after rAd5 alone was detected at 6 weeks; after DNA prime - rAd5 boost, at 6 months (end of study). At baseline, neutralizing antibodies against Ad5 were present in 81% of volunteers; the distribution was similar across the 4 groups. Pre-existing immunity to Ad5 did not appear to have a significant impact on reactogenicity or immune response rates to HIV antigens by IFN-γ ELISPOT. Binding antibodies against Env were detected in up to 100% recipients of DNA prime - rAd5 boost. One volunteer acquired HIV infection after the study ended, two years after receipt of rAd5 alone.The HIV-1 rAd5 vaccine, either alone or as a boost following HIV-1 DNA vaccine, was well-tolerated and immunogenic in African adults. DNA priming increased the frequency and magnitude of cellular and humoral immune responses, but there was no effect of rAd5 dosage on immunogenicity endpoints.ClinicalTrials.gov NCT00124007

Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study

Background: The Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-controlled trial of daily acyclovir for genital herpes (HSV-2) suppression among HIV-1/HSV-2 co-infected persons to reduce HIV-1 transmission to their HIV-1 susceptible partners, which requires recruitment of HIV-1 serodiscordant heterosexual couples. We describe the baseline characteristics of this cohort. Methods: HIV-1 serodiscordant heterosexual couples, in which the HIV-1 infected partner was HSV-2 seropositive, had a CD4 count ≥250 cells/mcL and was not on antiretroviral therapy, were enrolled at 14 sites in East and Southern Africa. Demographic, behavioral, clinical and laboratory characteristics were assessed. Results: Of the 3408 HIV-1 serodiscordant couples enrolled, 67% of the HIV-1 infected partners were women. Couples had cohabitated for a median of 5 years (range 2–9) with 28% reporting unprotected sex in the month prior to enrollment. Among HIV-1 susceptible participants, 86% of women and 59% of men were HSV-2 seropositive. Other laboratory-diagnosed sexually transmitted infections were uncommon (500 relative to <350, respectively, p<0.001). Conclusions: The Partners Study successfully enrolled a cohort of 3408 heterosexual HIV-1 serodiscordant couples in Africa at high risk for HIV-1 transmission. Follow-up of this cohort will evaluate the efficacy of acyclovir for HSV-2 suppression in preventing HIV-1 transmission and provide insights into biological and behavioral factors determining heterosexual HIV-1 transmission. Trial Registration ClinicalTrials.gov NCT0019451

A Comparison of Young Star Properties with Local Galactic Environment for LEGUS/LITTLE THINGS Dwarf Irregular Galaxies

We have explored the role environmental factors play in determining characteristics of young stellar objects in nearby dwarf irregular and blue compact dwarf galaxies. Star clusters are characterized by concentrations, masses, and formation rates; OB associations by mass and mass surface density; O stars by their numbers and near-ultraviolet absolute magnitudes; and H II regions by Hα surface brightnesses. These characteristics are compared to surrounding galactic pressure, stellar mass density, H I surface density, and star formation rate (SFR) surface density. We find no trend of cluster characteristics with environmental properties, implying that larger-scale effects are more important in determining cluster characteristics or that rapid dynamical evolution erases any memory of the initial conditions. On the other hand, the most massive OB associations are found at higher pressure and H I surface density, and there is a trend of higher H II region Hα surface brightness with higher pressure, suggesting that a higher concentration of massive stars and gas is found preferentially in regions of higher pressure. At low pressures we find massive stars but not bound clusters and OB associations. We do not find evidence for an increase of cluster formation efficiency as a function of SFR density. However, there is an increase in the ratio of the number of clusters to the number of O stars with increasing pressure, perhaps reflecting an increase in clustering properties with SFR

A Comparison of Young Star Properties with Local Galactic Environment for LEGUS/LITTLE THINGS Dwarf Irregular Galaxies

We have explored the role environmental factors play in determining characteristics of young stellar objects in nearby dwarf irregular and blue compact dwarf galaxies. Star clusters are characterized by concentrations, masses, and formation rates; OB associations by mass and mass surface density; O stars by their numbers and near-ultraviolet absolute magnitudes; and H ii regions by Hα surface brightnesses. These characteristics are compared to surrounding galactic pressure, stellar mass density, H i surface density, and star formation rate (SFR) surface density. We find no trend of cluster characteristics with environmental properties, implying that larger-scale effects are more important in determining cluster characteristics or that rapid dynamical evolution erases any memory of the initial conditions. On the other hand, the most massive OB associations are found at higher pressure and H i surface density, and there is a trend of higher H ii region Hα surface brightness with higher pressure, suggesting that a higher concentration of massive stars and gas is found preferentially in regions of higher pressure. At low pressures we find massive stars but not bound clusters and OB associations. We do not find evidence for an increase of cluster formation efficiency as a function of SFR density. However, there is an increase in the ratio of the number of clusters to the number of O stars with increasing pressure, perhaps reflecting an increase in clustering properties with SFR